GSK Investigational Site is a clinical research site located in Charlotte, North Carolina, United States 28209.
Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 210 clinical trials with 19 currently active.
Therapeutic areas: Herpes Zoster, Infection, Human Immunodeficiency Virus, Diabetes Mellitus, Type 2.
Sponsors: GlaxoSmithKline, ViiV Healthcare, Human Genome Sciences Inc., a GSK Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Charlotte
Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 210 clinical trials on record, with 19 currently active. Their work covers Herpes Zoster, Infection, Human Immunodeficiency Virus, Diabetes Mellitus, Type 2.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.